Revenue + Forward P/E
Guardant Health, Inc. (GH) quarterly revenue and forward P/E
RevenueRevenue (est)Forward P/E
Valuation
Market cap
$21.65B
Enterprise value
$20.91B
P/E ratio (TTM)
-44.92x
P/S ratio (TTM)
18.69x
P/B ratio
-110.41x
EV/Sales
19.36x
EV/EBITDA
-53.48x
Dividend yield
0.00%
Income statement (TTM)
Revenue (TTM)
$982.02M
Gross profit (TTM)
$633.01M
Operating income (TTM)
$-436.30M
EBITDA (TTM)
$-373.91M
Net income (TTM)
$-416.28M
Free cash flow (TTM)
$-233.07M
Margins & returns
Gross margin
64.90%
Operating margin
-41.43%
Profit margin
-40.10%
Return on equity
184.27%
Return on assets
-22.62%
Per-share metrics
EPS (TTM)
-$3.30
Dividend yield
0.00%
Beta
1.59
Capital structure
Cash & equivalents
$378.20M
Total debt
$1.71B
Net debt
$1.33B
Shares outstanding
134.20M
Financial health
Current ratio
4.84
Debt / equity
-17.22
Debt / assets
0.85
Interest coverage
-111.96
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
| $1.15T | 42.41x | 15.59x | 34.80x | 0.54% | |
| $630.50B | 30.45x | 6.47x | 20.76x | 1.99% | |
| $443.32B | 127.13x | 7.29x | 30.82x | 2.63% | |
| $365.18B | 27.06x | 0.85x | 16.46x | 2.13% | |
| $354.73B | 23.91x | 4.80x | 15.14x | 2.67% | |
| $333.06B | 36.82x | 4.94x | 19.57x | 2.56% | |
| $21.65B | -44.92x | 18.69x | -53.48x | - |